Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,494 | 863 | 99.7% |
| Education | $43.59 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,062 | 120 | $0 (2024) |
| ABBVIE INC. | $1,857 | 105 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,420 | 80 | $0 (2024) |
| Lilly USA, LLC | $1,063 | 59 | $0 (2024) |
| PFIZER INC. | $766.36 | 36 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $710.31 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $692.58 | 39 | $0 (2022) |
| Amgen Inc. | $638.78 | 40 | $0 (2024) |
| Allergan, Inc. | $532.24 | 48 | $0 (2020) |
| GlaxoSmithKline, LLC. | $492.25 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,894 | 89 | PFIZER INC. ($296.49) |
| 2023 | $1,682 | 87 | Novo Nordisk Inc ($380.39) |
| 2022 | $1,488 | 88 | ABBVIE INC. ($463.53) |
| 2021 | $1,739 | 98 | AbbVie Inc. ($493.74) |
| 2020 | $1,580 | 102 | Novo Nordisk Inc ($211.63) |
| 2019 | $1,792 | 122 | AstraZeneca Pharmaceuticals LP ($291.27) |
| 2018 | $1,852 | 114 | AstraZeneca Pharmaceuticals LP ($499.56) |
| 2017 | $2,510 | 168 | AstraZeneca Pharmaceuticals LP ($299.66) |
All Payment Transactions
868 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $29.30 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: PAIN | ||||||
| 12/06/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: VACCINE | ||||||
| 11/21/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.32 | General |
| Category: PAIN | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: RESPIRATORY | ||||||
| 11/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: DIABETES | ||||||
| 11/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $32.56 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: PAIN | ||||||
| 10/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/09/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 10/08/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $27.23 | General |
| Category: Obesity | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,038 | 1,288 | $184,156 | $84,732 |
| 2022 | 18 | 1,001 | 1,277 | $155,772 | $68,853 |
| 2021 | 16 | 934 | 1,224 | $142,759 | $66,052 |
| 2020 | 11 | 726 | 934 | $94,505 | $38,783 |
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 137 | 272 | $53,208 | $24,954 | 46.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $30,498 | $15,478 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 93 | 142 | $18,564 | $9,463 | 51.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 141 | 141 | $24,933 | $8,568 | 34.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $10,170 | $7,628 | 75.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 25 | 25 | $5,625 | $3,212 | 57.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $4,316 | $2,819 | 65.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 22 | $5,990 | $2,788 | 46.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 27 | 27 | $2,305 | $1,901 | 82.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 112 | 120 | $9,712 | $1,384 | 14.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 89 | 135 | $2,664 | $1,134 | 42.6% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 28 | 28 | $6,475 | $1,133 | 17.5% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 25 | 25 | $1,875 | $1,077 | 57.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $1,218 | $937.28 | 77.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,130 | $872.64 | 77.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 34 | 34 | $1,850 | $601.46 | 32.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 31 | $1,249 | $507.52 | 40.6% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 15 | 15 | $1,218 | $144.82 | 11.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 55 | 59 | $1,156 | $129.80 | 11.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 120 | 241 | $45,549 | $21,949 | 48.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $26,000 | $13,990 | 53.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 149 | $18,774 | $10,051 | 53.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 123 | 123 | $20,910 | $7,128 | 34.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $3,900 | $2,693 | 69.0% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 34 | 34 | $2,735 | $2,327 | 85.1% |
About Dr. Videsha Kulkarni, MD
Dr. Videsha Kulkarni, MD is a Internal Medicine healthcare provider based in Glenview, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215988126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Videsha Kulkarni, MD has received a total of $14,537 in payments from pharmaceutical and medical device companies, with $1,894 received in 2024. These payments were reported across 868 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($14,494).
As a Medicare-enrolled provider, Kulkarni has provided services to 3,699 Medicare beneficiaries, totaling 4,723 services with total Medicare billing of $258,419. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Glenview, IL
- Active Since 05/15/2006
- Last Updated 10/15/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215988126
Products in Payments
- VRAYLAR (Drug) $883.34
- FARXIGA (Drug) $831.64
- JARDIANCE (Drug) $663.03
- XARELTO (Drug) $573.05
- UBRELVY (Drug) $558.68
- Saxenda (Drug) $504.08
- UNITHROID (Drug) $452.39
- NURTEC ODT (Drug) $420.80
- Ozempic (Drug) $351.86
- SYMBICORT (Drug) $314.10
- CONTRAVE (Drug) $296.79
- Victoza (Drug) $295.19
- TRADJENTA (Drug) $273.11
- Trintellix (Drug) $267.44
- TRELEGY ELLIPTA (Drug) $259.15
- PREVNAR 20 (Biological) $247.63
- SYNTHROID (Drug) $242.87
- Aimovig (Biological) $226.89
- Vascepa (Drug) $220.49
- Rybelsus (Drug) $214.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Glenview
Jose Nazari, Md, MD
Internal Medicine — Payments: $25,736
Dr. Thomas Ficho, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $20,710
Sheree Lipkis, Md, MD
Internal Medicine — Payments: $13,193
Evan Lipkis, Md, MD
Internal Medicine — Payments: $10,604
Dr. Najam Saqib, M.d, M.D
Internal Medicine — Payments: $9,427
Dr. Frank Weschler, M.d, M.D
Internal Medicine — Payments: $8,187